MBL Obtained manufacturing and marketing approval a Kit for Simultaneous Detection of SARS-CoV-2 and Influenza Virus Antigens
Products
MBL obtained manufacturing and marketing approval on September 14, 2022 for its new GLINE-SARS-CoV-2 & FluA+B Kit, a simple test kit that simultaneously detects both the SARS-CoV-2 antigen and influenza virus antigen in a single test cassette. Sales will begin in a few weeks.
This kit detects the SARS-CoV-2 antigen, influenza A virus antigen, and influenza B virus antigen in nasopharyngeal or nasal swab fluid using a immunochromatographic method.